Tracking development assistance for health from China, 2007-2017.

Health economics Health policy Health systems

Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
2019
Historique:
received: 16 02 2019
revised: 12 08 2019
accepted: 18 08 2019
entrez: 25 10 2019
pubmed: 28 10 2019
medline: 28 10 2019
Statut: epublish

Résumé

In recent years, China has increased its international engagement in health. Nonetheless, the lack of data on contributions has limited efforts to examine contributions from China. Existing estimates that track development assistance for health (DAH) from China have relied primarily on one dataset. Furthermore, little is known about the disbursing agencies especially the multilaterals through which contributions are disbursed and how these are changing across time. In this study, we generated estimates of DAH from China from 2007 through 2017 and disaggregated those estimates by disbursing agency and health focus area. We identified the major government agencies providing DAH. To estimate DAH provided by each agency, we leveraged publicly available development assistance data in government agencies' budgets and financial accounts, as well as revenue statements from key international development agencies such as the WHO. We reported trends in DAH from China, disaggregated contributions by disbursing bilateral and multilateral agencies, and compared DAH from China with other traditional donors. We also compared these estimates with existing estimates. DAH provided by China grew dramatically, from US$323.1 million in 2007 to $652.3 million in 2017. During this period, 91.8% of DAH from China was disbursed through its bilateral agencies, including the Ministry of Commerce ($3.7 billion, 64.1%) and the National Health Commission ($917.1 million, 16.1%); the other 8.2% was disbursed through multilateral agencies including the WHO ($236.5 million, 4.1%) and the World Bank ($123.1 million, 2.2%). Relative to its level of economic development, China provided substantially more DAH than would be expected. However, relative to population size and government spending, China's contributions are modest. In the current context of plateauing in the growth rate of DAH contributions, China has the potential to contribute to future global health financing, especially financing for health system strengthening.

Identifiants

pubmed: 31646007
doi: 10.1136/bmjgh-2019-001513
pii: bmjgh-2019-001513
pmc: PMC6782043
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e001513

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet. 2018 Sep 22;392(10152):998-999
pubmed: 30264715
Glob Health Res Policy. 2017 Aug 9;2:24
pubmed: 29202092
Lancet. 2019 Jun 1;393(10187):2233-2260
pubmed: 31030984
Lancet. 2015 Dec 12;386(10011):2379-80
pubmed: 26700520
Lancet. 2018 Aug 25;392(10148):636
pubmed: 30152343
Lancet. 2017 Dec 9;390(10112):2595-2601
pubmed: 29231838
Global Health. 2014 Dec 30;10:84
pubmed: 25547314
Glob Chall. 2017 Jan 30;1(2):1600001
pubmed: 31565261

Auteurs

Angela E Micah (AE)

Institute for Health Metrics and Evaluation, Seattle, Washington, USA.

Yingxi Zhao (Y)

Institute for Health Metrics and Evaluation, Seattle, Washington, USA.

Catherine S Chen (CS)

Institute for Health Metrics and Evaluation, Seattle, Washington, USA.

Bianca S Zlavog (BS)

Institute for Health Metrics and Evaluation, Seattle, Washington, USA.

Golsum Tsakalos (G)

Institute for Health Metrics and Evaluation, Seattle, Washington, USA.

Abigail Chapin (A)

Institute for Health Metrics and Evaluation, Seattle, Washington, USA.

Stephen Gloyd (S)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Jost Jonas (J)

Ophthalmology, Medical Faculty Mannheim of the Ruprecht Karl University of Heidelberg, Mannheim, Germany.

Paul H Lee (PH)

School of Nursing, Hong Kong Polytechnic University, Hong Kong, China.

Shiwei Liu (S)

National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, Hubei, China.

Man Tat Alexander Ng (MTA)

Tencent Healthcare, Shenzhen, Guangdong, China.

Michael R Phillips (MR)

Shanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China.

Enrico Rubagotti (E)

Biotechnology, Universidad Regional Amazónica Ikiam, Ciudad de Tena, Napo, Ecuador.

Kun Tang (K)

Research Center for Public Health, Tsinghua University School of Medicine, Beijing, Hubei, China.

Shenglan Tang (S)

Duke Global Health Institute, Duke University, Durham, North Carolina, USA.

Mustafa Younis (M)

Department of Health Economics & Management, Jackson State University, Jackson, Mississippi, USA.

Yunquan Zhang (Y)

Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Public Health, Wuhan University of Science and Technology, Wuhan, Hubei, China.

Christopher J L Murray (CJL)

Institute for Health Metrics and Evaluation, Seattle, Washington, USA.

Joseph L Dieleman (JL)

Institute for Health Metrics and Evaluation, Seattle, Washington, USA.

Classifications MeSH